Related Experiment Videos
[Direct detection of mutations in the LDL receptor gene in patients with familial hypercholesterolemia]
T Freiberger1, V Kuhrová, L Kozák
1Výzkumný ústav zdraví dítĕte, Brno.
Insights
This study identified 11 mutations in the LDL receptor gene among Czech patients with familial hypercholesterolemia, including 7 novel mutations. Early genetic detection aids in preventing cardiovascular events.
Area of Science:
- Genetics
- Metabolic Diseases
- Cardiovascular Research
Context:
- Familial hypercholesterolemia (FH) is a common hereditary metabolic disorder.
- Impaired LDL receptor function leads to elevated blood cholesterol and atherosclerosis.
- Direct mutation detection is crucial for accurate FH diagnosis.
Purpose:
- To introduce direct detection of LDL receptor gene mutations.
- To characterize the spectrum of LDL receptor gene mutations in the Czech population.
Summary:
- Analyzed 84 FH patients; 12 had apolipoprotein B-100 mutations (familial defect of apo B-100).
- Found 11 LDL receptor gene mutations in 14 patients, including 7 novel mutations.
- This is the first systematic mutation spectrum analysis in the Czech Republic.
Impact:
- Molecular genetic analysis enables early FH diagnosis.
- Facilitates timely intervention to prevent cardiovascular events.
- Contributes to personalized medicine for hereditary hypercholesterolemia.
Background:
Familial hypercholesterolemia is one of the most frequent hereditary metabolic diseases. As a result of the functional disorder of the molecule of the LDL receptor LDL cholesterol is not sufficiently eliminated from the blood stream and exerts an atherogenic effect. The objective of the study was to introduce direct detection of mutations in the gene for the LDL receptor and characterize the spectrum of mutations in the Czech population.
Methods And Results:
The authors analyzed a group of 84 unrelated patients where on the basis of clinical and biochemical criteria the diagnosis of FH was established. From the group 12 patients were eliminated (14.3%) where a mutation 3500 in the gene for apolipoprotein (apo) B-100 was detected. This mutation is most frequently the cause of a familial defect of apo B-100 (FDB), which cannot be differentiated clinically or biochemically from FH. In the LDL receptor gene a total of 11 mutations were found in 14 unrelated patients (16.7%), incl. 7 mutations not described hitherto.
Conclusions:
This is the first systematic characteristic of the spectrum of mutations in the LDL receptor gene in the Czech population. Molecular genetic analysis of the gene for the LDL receptor in affected families can contribute towards early assessment of the diagnosis of FH and thus to prevention of life threatening cardiovascular episodes in asymptomatic subjects.